214 related articles for article (PubMed ID: 30474946)
1. [Radionuclide therapy for bone metastases by drugs based on Re-188].
Liepe K; Krylov VV; Kochetova TY
Vopr Onkol; 2016; 62(4):401-9. PubMed ID: 30474946
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
Liepe K; Franke WG; Kropp J; Koch R; Runge R; Hliscs R
Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
[TBL] [Abstract][Full Text] [Related]
3. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
Küçük NO; Ibiş E; Aras G; Baltaci S; Ozalp G; Bedük Y; Canakci N; Soylu A
Ann Nucl Med; 2000 Aug; 14(4):239-45. PubMed ID: 11023023
[TBL] [Abstract][Full Text] [Related]
4. Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
Lange R; Overbeek F; de Klerk JM; Pasker-de Jong PC; van den Berk AM; Ter Heine R; Rodenburg CJ; Kooistra A; Hendrikse NH; Bloemendal HJ
Nuklearmedizin; 2016 Sep; 55(5):188-95. PubMed ID: 27443809
[TBL] [Abstract][Full Text] [Related]
5. 186Re-HEDP for metastatic bone pain in breast cancer patients.
Lam MG; de Klerk JM; van Rijk PP
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846
[TBL] [Abstract][Full Text] [Related]
6. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
Schoeneich G; Palmedo H; Dierke-Dzierzon C; Müller SC; Biersack HJ
Scand J Urol Nephrol; 1997 Oct; 31(5):445-8. PubMed ID: 9406304
[TBL] [Abstract][Full Text] [Related]
7. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Liepe K; Kropp J; Hliscs R; Franke WG
Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
[TBL] [Abstract][Full Text] [Related]
8. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
Róka R; Séra T; Pajor L; Thurzó L; Láng J; Csernay L; Pávics L
Orv Hetil; 2000 May; 141(19):1019-23. PubMed ID: 10846424
[TBL] [Abstract][Full Text] [Related]
9. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
Sciuto R; Festa A; Pasqualoni R; Semprebene A; Rea S; Bergomi S; Maini CL
Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096
[TBL] [Abstract][Full Text] [Related]
10. [Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP].
Hauswirth AE; Palmedo H; Dierke-Dzierzon C; Biersack HJ; Krebs D
Zentralbl Gynakol; 1998; 120(2):83-6. PubMed ID: 9531713
[TBL] [Abstract][Full Text] [Related]
11. Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
Palmedo H; Grünwald F; Wagner U; Köhler S; Krebs D; Biersack HJ
Clin Nucl Med; 1998 Aug; 23(8):501-4. PubMed ID: 9712380
[TBL] [Abstract][Full Text] [Related]
12. [Pain therapy with rhenium-186 HEDP in multiple bone metastases].
Palmedo H; Bender H; Schomburg A; Grünwald F; Schöneich G; Zamorra P; Reichmann K; Dierke-Dzierzon C; Mallmann P; Biersack HJ
Nuklearmedizin; 1996 Apr; 35(2):63-7. PubMed ID: 8721578
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
Liepe K; Kropp J; Runge R; Kotzerke J
Br J Cancer; 2003 Aug; 89(4):625-9. PubMed ID: 12915868
[TBL] [Abstract][Full Text] [Related]
14. Systemic radionuclide therapy in pain palliation.
Liepe K; Runge R; Kotzerke J
Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
[TBL] [Abstract][Full Text] [Related]
16. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP].
Klutmann S; Bohuslavizki KH
MMW Fortschr Med; 1999 Nov; 141(44):38-9. PubMed ID: 10912142
[TBL] [Abstract][Full Text] [Related]
17. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
Rubini G; Nicoletti A; Rubini D; Asabella AN
Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
[TBL] [Abstract][Full Text] [Related]
18. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.
Knapp FF; Beets AL; Guhlke S; Zamora PO; Bender H; Palmedo H; Biersack HJ
Anticancer Res; 1997; 17(3B):1783-95. PubMed ID: 9179235
[TBL] [Abstract][Full Text] [Related]
19. Labelling of Re-ABP with 188Re for bone pain palliation.
Arteaga de Murphy C; Ferro-Flores G; Pedraza-López M; Meléndez-Alafort L; Croft BY; Ramírez FM; Padilla J
Appl Radiat Isot; 2001 Mar; 54(3):435-42. PubMed ID: 11214878
[TBL] [Abstract][Full Text] [Related]
20. Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases.
Palmedo H; Bender H; Dierke-Dzierzon C; Carl UM; Risse J; Krebs D; Biersack HJ
Clin Nucl Med; 1999 Sep; 24(9):643-8. PubMed ID: 10478737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
